Petersen I
Int J Mol Sci. 2021; 22(17).
PMID: 34502326
PMC: 8431301.
DOI: 10.3390/ijms22179418.
Rizeq B, Sif S, Nasrallah G, Ouhtit A
J Cell Mol Med. 2020; 24(19):11477-11488.
PMID: 32888398
PMC: 7576304.
DOI: 10.1111/jcmm.15761.
Lin C, Tan X, Chen M, Kusi M, Hung C, Chou C
BMC Med Genomics. 2020; 13(1):69.
PMID: 32408897
PMC: 7222439.
DOI: 10.1186/s12920-020-0729-7.
Teixeira V, Pipinikas C, Pennycuick A, Lee-Six H, Chandrasekharan D, Beane J
Nat Med. 2019; 25(3):517-525.
PMID: 30664780
PMC: 7614970.
DOI: 10.1038/s41591-018-0323-0.
Gaspar T, Sa A, Lopes J, Sobrinho-Simoes M, Soares P, Vinagre J
Genes (Basel). 2018; 9(5).
PMID: 29751586
PMC: 5977181.
DOI: 10.3390/genes9050241.
Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?.
Zhao X, McCutcheon J, Kallakury B, Chahine J, Pratt D, Raffeld M
J Thorac Oncol. 2017; 13(2):237-245.
PMID: 29101056
PMC: 8057113.
DOI: 10.1016/j.jtho.2017.10.010.
The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
Fields A, Justilien V, Murray N
Adv Biol Regul. 2016; 60:47-63.
PMID: 26754874
PMC: 4729592.
DOI: 10.1016/j.jbior.2015.10.009.
The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer.
Honda K
Cell Biosci. 2015; 5:41.
PMID: 26288717
PMC: 4539665.
DOI: 10.1186/s13578-015-0031-0.
Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Semenova E, Nagel R, Berns A
Genes Dev. 2015; 29(14):1447-62.
PMID: 26220992
PMC: 4526731.
DOI: 10.1101/gad.263145.115.
Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.
Igci M, Arslan A, Erturhan S, Igci Y, Pala E, Gogebakan B
Mol Biol Rep. 2014; 42(2):507-16.
PMID: 25324173
DOI: 10.1007/s11033-014-3794-1.
p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.
Hong S, Moon J, Kim J, Shin J, Jung K, Lee W
Cell Death Differ. 2013; 21(1):146-60.
PMID: 24141722
PMC: 3857621.
DOI: 10.1038/cdd.2013.141.
FGFR1 expression and gene copy numbers in human lung cancer.
Kohler L, Mireskandari M, Knosel T, Altendorf-Hofmann A, Kunze A, Schmidt A
Virchows Arch. 2012; 461(1):49-57.
PMID: 22648708
DOI: 10.1007/s00428-012-1250-y.
A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.
Liu Y, Wang Z, Fang L, Li L, Cao J, Xu X
J Cancer Res Clin Oncol. 2012; 138(9):1541-9.
PMID: 22538453
DOI: 10.1007/s00432-012-1232-0.
Novel strategies for the treatment of small-cell lung carcinoma.
William Jr W, Glisson B
Nat Rev Clin Oncol. 2011; 8(10):611-9.
PMID: 21691321
DOI: 10.1038/nrclinonc.2011.90.
DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway.
Ocak S, Yamashita H, Udyavar A, Miller A, Gonzalez A, Zou Y
Oncogene. 2010; 29(48):6331-42.
PMID: 20802517
PMC: 4637980.
DOI: 10.1038/onc.2010.362.
Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis.
Prindiville S, Ried T
Cancer Prev Res (Phila). 2010; 3(4):416-9.
PMID: 20332302
PMC: 2864589.
DOI: 10.1158/1940-6207.CAPR-10-0045.
19q13 amplification is associated with high grade and stage in pancreatic cancer.
Kuuselo R, Simon R, Karhu R, Tennstedt P, Marx A, Izbicki J
Genes Chromosomes Cancer. 2010; 49(6):569-75.
PMID: 20232484
PMC: 2855495.
DOI: 10.1002/gcc.20767.
Role of cell cycle regulators in lung carcinogenesis.
Eymin B, Gazzeri S
Cell Adh Migr. 2010; 4(1):114-23.
PMID: 20139697
PMC: 2852568.
DOI: 10.4161/cam.4.1.10977.
Emerging roles of E2Fs in cancer: an exit from cell cycle control.
Chen H, Tsai S, Leone G
Nat Rev Cancer. 2009; 9(11):785-97.
PMID: 19851314
PMC: 3616489.
DOI: 10.1038/nrc2696.
TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.
Cheong J, Gunaratnam L, Zang Z, Yang C, Sun X, Nasr S
J Transl Med. 2009; 7:8.
PMID: 19152710
PMC: 2671481.
DOI: 10.1186/1479-5876-7-8.